PASW Ping An Biomedical Co., Ltd.

Fundamentals / CIK 0001897532 / CNY

Ping An Biomedical Co., Ltd. reported ¥34.15M in revenue and a net loss of ¥12.83M for the fiscal year ended September 30, 2025 (down 61.0% year over year), with a 2.8% gross margin and a -43.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PASW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in CNY.

¥87.72M¥43.86M¥0-¥19.44MFY 2023 Revenue: ¥82.56MFY 2023 Net Income: -¥994K2023FY 2024 Revenue: ¥87.62MFY 2024 Net Income: -¥1.28M2024FY 2025 Revenue: ¥34.15MFY 2025 Net Income: -¥12.83M2025

Financial statements and ratios

Reported in CNY. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in CNY · Newest filing period first.

Income Statement Sep 30 Sep 30 Sep 30
Revenue ¥34.15M ¥87.62M ¥82.56M
Cost of Revenue ¥33.20M ¥82.21M ¥78.32M
Gross Profit ¥950K ¥5.42M ¥4.24M
Selling, General & Admin ¥6.31M ¥5.30M ¥3.60M
Total Operating Expenses ¥15.65M ¥5.42M ¥3.63M
Operating Income -¥14.70M -¥2.0K ¥612K
EBITDA -¥14.70M ¥8.2K ¥645K
Interest Income ¥326K ¥2.0K ¥156K
Interest Expense ¥307K ¥705K ¥1.74M
Income Before Tax -¥14.68M -¥683K ¥42K
Income Tax Expense ¥1.86M -¥601K -¥1.04M
Net Income -¥12.83M -¥1.28M -¥994K
Basic EPS -¥0.69 -¥0.07 -¥0.06
Diluted EPS -¥0.69 -¥0.07 -¥0.06
Basic Shares Outstanding 18.5M 18.0M 18.0M
Diluted Shares Outstanding 18.5M 18.0M 18.0M

Income Statement (Quarterly) · Reported in CNY · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for PASW.

Balance Sheet (Annual) · Reported in CNY · Newest filing period first.

Balance Sheet Sep 30 Sep 30
Cash & Cash Equivalents ¥1.17M ¥131K
Cash & Short-Term Investments ¥1.17M ¥131K
Accounts Receivable, Net ¥16.93M ¥40.44M
Inventory ¥442K ¥127K
Total Current Assets ¥63.70M ¥53.31M
Property, Plant & Equipment, Net -- ¥5.6K
Total Non-Current Assets ¥4.72M ¥3.54M
Total Assets ¥68.41M ¥56.85M
Accounts Payable ¥9.41M ¥15.06M
Short-Term Debt ¥10.00M ¥10.00M
Deferred Revenue (Current) ¥70K ¥1.67M
Total Current Liabilities ¥23.08M ¥63.58M
Total Non-Current Liabilities ¥96K ¥461K
Total Liabilities ¥23.17M ¥64.04M
Total Debt (incl. Leases) ¥10.47M ¥10.81M
Common Stock ¥8.4K ¥7.3K
Retained Earnings -¥21.05M -¥8.22M
Accumulated Other Comp. Income -¥1.61M -¥657K
Total Stockholders' Equity ¥45.24M -¥7.19M
Total Equity ¥45.24M -¥7.19M

Balance Sheet (Quarterly) · Reported in CNY · Newest filing period first.

Balance Sheet 2025-09-30 2024-09-30
Cash & Cash Equivalents ¥1.17M ¥131K
Cash & Short-Term Investments ¥1.17M ¥131K
Accounts Receivable, Net ¥16.93M ¥40.44M
Inventory ¥442K ¥127K
Total Current Assets ¥63.70M ¥53.31M
Property, Plant & Equipment, Net -- ¥5.6K
Total Non-Current Assets ¥4.72M ¥3.54M
Total Assets ¥68.41M ¥56.85M
Accounts Payable ¥9.41M ¥15.06M
Short-Term Debt ¥10.00M ¥10.00M
Deferred Revenue (Current) ¥70K ¥1.67M
Total Current Liabilities ¥23.08M ¥63.58M
Total Non-Current Liabilities ¥96K ¥461K
Total Liabilities ¥23.17M ¥64.04M
Total Debt (incl. Leases) ¥10.47M ¥10.81M
Common Stock ¥8.4K ¥7.3K
Retained Earnings -¥21.05M -¥8.22M
Accumulated Other Comp. Income -¥1.61M -¥657K
Total Stockholders' Equity ¥45.24M -¥7.19M
Total Equity ¥45.24M -¥7.19M

Cash Flow Statement (Annual) · Reported in CNY · Newest filing period first.

Cash Flow Statement Sep 30 Sep 30 Sep 30
Net Income -¥12.83M -¥1.28M -¥994K
Depreciation & Amortization ¥5.6K ¥10K ¥33K
Change in Receivables ¥14.17M ¥6.53M ¥9.88M
Change in Inventory -¥308K ¥3.06M ¥1.44M
Change in Payables -¥5.64M ¥5.78M -¥8.76M
Operating Cash Flow -¥6.43M ¥14.63M -¥6.08M
Investing Cash Flow ¥0 ¥15.00M -¥3.37M
Dividends Paid -- -¥322K -¥9.60M
Financing Cash Flow ¥43.66M -¥30.09M ¥8.87M
Net Change in Cash ¥37.23M -¥459K -¥576K

Cash Flow Statement (Quarterly) · Reported in CNY · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for PASW.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Sep 30 Sep 30 Sep 30
Gross Margin 2.8% 6.2% 5.1%
Operating Margin -43.1% 0.0% 0.7%
Net Profit Margin -37.6% -1.5% -1.2%
Return on Equity (ROE) -28.4% -- --
Return on Assets (ROA) -18.8% -2.3% --
Current Ratio 2.76x 0.84x --
Quick Ratio 2.74x 0.84x --
Debt to Equity 0.23x -- --
Revenue Growth (YoY) -61.0% +6.1% --
Gross Profit Growth (YoY) -82.5% +27.8% --
Operating Income Growth (YoY) -- -100.3% --
Operating Cash Flow Growth (YoY) -143.9% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for PASW.
Source: SEC EDGAR CompanyFacts (CIK 0001897532) · from September 30, 2023 Data through September 30, 2025 · synced Nov 21, 2026, 05:10 UTC · Open in terminal